262 related articles for article (PubMed ID: 6092554)
41. A randomized trial of alternating chemotherapy versus best supportive care in advanced non-small-cell lung cancer.
Cellerino R; Tummarello D; Guidi F; Isidori P; Raspugli M; Biscottini B; Fatati G
J Clin Oncol; 1991 Aug; 9(8):1453-61. PubMed ID: 1649267
[TBL] [Abstract][Full Text] [Related]
42. Cyclic-alternating versus response-oriented chemotherapy in small-cell lung cancer: a German multicenter randomized trial of 321 patients.
Wolf M; Pritsch M; Drings P; Hans K; Schroeder M; Flechtner H; Heim M; Hruska D; Mende S; Becker H
J Clin Oncol; 1991 Apr; 9(4):614-24. PubMed ID: 1648598
[TBL] [Abstract][Full Text] [Related]
43. [Antineoplastic chemotherapy for bronchial carcinoma].
Tanneberger S
Arch Geschwulstforsch; 1985; 55(1):63-71. PubMed ID: 2985017
[TBL] [Abstract][Full Text] [Related]
44. Three-drug chemotherapy combined with radiation therapy in small cell carcinoma of the lung.
Sibille Y; Steyaert J; Francis C; Bosly A; Prignot J
Eur J Respir Dis; 1983 Feb; 64(2):113-20. PubMed ID: 6299770
[TBL] [Abstract][Full Text] [Related]
45. Combination chemotherapy of limited-stage small-cell lung cancer. A controlled trial on 221 patients comparing two alternating regimens.
Osterlind K; Hansen M; Hirsch FR; Dombernowsky P; Sörenson S; Pedersen AG; Hansen HH
Ann Oncol; 1991 Jan; 2(1):41-6. PubMed ID: 1848996
[TBL] [Abstract][Full Text] [Related]
46. Alternating chemotherapy with cyclophosphamide/adriamycin/vincristine (CAV) and cisplatin/etoposide (PVP) against small cell lung cancer. Eastern Shikoku Lung Cancer Chemotherapy Group.
Bando H; Takishita Y; Ogura T; Sone S; Shimizu E; Nakayama T; Doi H; Kobayashi M
Jpn J Clin Oncol; 1991 Dec; 21(6):435-9. PubMed ID: 1666660
[TBL] [Abstract][Full Text] [Related]
47. Dose-intensive weekly alternating chemotherapy for patients with small cell lung cancer: randomized trial, can it improve survival of patients with good prognostic factors?
Masutani M; Ochi Y; Kadota A; Akusawa H; Kisohara A; Takahashi N; Koya Y; Horie T
Oncol Rep; 2000; 7(2):305-10. PubMed ID: 10671676
[TBL] [Abstract][Full Text] [Related]
48. Late intensification chemotherapy with autologous bone marrow transplantation in selected small-cell carcinoma of the lung: a randomized study.
Humblet Y; Symann M; Bosly A; Delaunois L; Francis C; Machiels J; Beauduin M; Doyen C; Weynants P; Longueville J
J Clin Oncol; 1987 Dec; 5(12):1864-73. PubMed ID: 2824708
[TBL] [Abstract][Full Text] [Related]
49. Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years' follow-up.
Sundstrøm S; Bremnes RM; Kaasa S; Aasebø U; Hatlevoll R; Dahle R; Boye N; Wang M; Vigander T; Vilsvik J; Skovlund E; Hannisdal E; Aamdal S;
J Clin Oncol; 2002 Dec; 20(24):4665-72. PubMed ID: 12488411
[TBL] [Abstract][Full Text] [Related]
50. A randomized comparison of standard chemotherapy versus alternating chemotherapy and maintenance versus no maintenance therapy for extensive-stage small-cell lung cancer: a phase III study of the Eastern Cooperative Oncology Group.
Ettinger DS; Finkelstein DM; Abeloff MD; Ruckdeschel JC; Aisner SC; Eggleston JC
J Clin Oncol; 1990 Feb; 8(2):230-40. PubMed ID: 2153765
[TBL] [Abstract][Full Text] [Related]
51. Cyclic alternating chemotherapy for small cell carcinoma of the lung.
Murray N; Shah A; Wilson K; Goldie J; Voss N; Fryer C; Klimo P; Coy P; Hadzic E; Gudauskas G
Cancer Treat Rep; 1985 Nov; 69(11):1241-2. PubMed ID: 3004724
[TBL] [Abstract][Full Text] [Related]
52. Multiple-drug weekly chemotherapy versus standard combination regimen in small-cell lung cancer: a phase III randomized study conducted by the European Lung Cancer Working Party.
Sculier JP; Paesmans M; Bureau G; Dabouis G; Libert P; Vandermoten G; Van Cutsem O; Berchier MC; Ries F; Michel J
J Clin Oncol; 1993 Oct; 11(10):1858-65. PubMed ID: 8410110
[TBL] [Abstract][Full Text] [Related]
53. A randomized clinical trial comparing concurrent and alternating thoracic irradiation for patients with limited small cell lung carcinoma. "Petites Cellules" Group.
Lebeau B; Urban T; Bréchot JM; Paillotin D; Vincent J; Leclerc P; Meekel P; L'Her P; Lebas FX; Chastang C
Cancer; 1999 Oct; 86(8):1480-7. PubMed ID: 10526276
[TBL] [Abstract][Full Text] [Related]
54. VP-16-213 in combination chemotherapy with chest irradiation for small-cell lung cancer: a randomized trial of the Piedmont Oncology Association.
Jackson DV; Zekan PJ; Caldwell RD; Slatkoff ML; Harding RW; Case LD; Hopkins JO; Muss HB; Richards F; White DR
J Clin Oncol; 1984 Dec; 2(12):1343-51. PubMed ID: 6096517
[TBL] [Abstract][Full Text] [Related]
55. Alternating cycles of combination chemotherapy for patients with recurrent Hodgkin's disease following radiotherapy. A prospectively randomized study by the Cancer and Leukemia Group B.
Vinciguerra V; Propert KJ; Coleman M; Anderson JR; Stutzman L; Pajak TF; Nissen NI; Frizzera G; Gottlieb A; Holland JF
J Clin Oncol; 1986 Jun; 4(6):838-46. PubMed ID: 2423652
[TBL] [Abstract][Full Text] [Related]
56. Sequencing and schedule effects of cisplatin plus etoposide in small-cell lung cancer: results of a North Central Cancer Treatment Group randomized clinical trial.
Maksymiuk AW; Jett JR; Earle JD; Su JQ; Diegert FA; Mailliard JA; Kardinal CG; Krook JE; Veeder MH; Wiesenfeld M
J Clin Oncol; 1994 Jan; 12(1):70-6. PubMed ID: 8270988
[TBL] [Abstract][Full Text] [Related]
57. Combination cyclophosphamide, Adriamycin, and vincristine rapidly alternating with combination cisplatin and VP-16 in treatment of small cell lung cancer.
Natale RB; Shank B; Hilaris BS; Wittes RE
Am J Med; 1985 Sep; 79(3):303-8. PubMed ID: 2994472
[TBL] [Abstract][Full Text] [Related]
58. [Adriamycin, cyclophosphamide, vincristine and methotrexate combination chemotherapy of small cell lung cancer].
Saito H; Kawatsu H; Saka H; Yamamoto M; Takagi E; Tsunekawa H; Kawachi H; Nagura E; Sakai S; Nishiwaki K
Gan To Kagaku Ryoho; 1988 Jun; 15(6):1909-13. PubMed ID: 2838000
[TBL] [Abstract][Full Text] [Related]
59. Randomized trial of alternating versus sequential radiotherapy/chemotherapy in limited-disease patients with small-cell lung cancer: a European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group Study.
Gregor A; Drings P; Burghouts J; Postmus PE; Morgan D; Sahmoud T; Kirkpatrick A; Dalesio O; Giaccone G
J Clin Oncol; 1997 Aug; 15(8):2840-9. PubMed ID: 9256127
[TBL] [Abstract][Full Text] [Related]
60. Doxorubicin, Cyclophosphamide and VP16-213 (ACE) in the treatment of small cell lung cancer.
Aisner J; Whitacre M; VanEcho DA; Wesley M; Wiernik PH
Cancer Chemother Pharmacol; 1982; 7(2-3):187-93. PubMed ID: 6282482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
